Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Medtronic’s acquisition of Companion Medical brought a smart insulin pen, the InPen, into its diabetes care lineup. This move signals a bigger push into managing diabetes for people who use injections ...
Hosted on MSN
1 Growth Stock Down 6% to Buy Right Now
You can break the stock market into different components, such as investing styles. These are growth and value stocks. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every ...
On Tuesday, Mizuho (NYSE:MFG) Securities adjusted its outlook on shares of Medtronic , Inc. (NYSE:NYSE:MDT), a global leader in medical technology, by increasing the price target on the company's ...
CGM technology could become a cornerstone in modern diabetes management. Credit: Halfpoint via Shutterstock. In an advancement for diabetes management, the US Food and Drug Administration (FDA) has ...
Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...
Medtronic received Food and Drug Administration clearance for its new InPen smart insulin pen app that can recommend corrections for missed or inaccurate insulin doses at mealtime. The authorization ...
GALWAY, Ireland - Medtronic has received clearance from the U.S. Food and Drug Administration for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI ...
New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results